Stockscreener 앱 받기
10.31
0.77%
-0.08
시간 외 거래:
10.32
0.010
+0.10%
전일 마감가:
$10.39
열려 있는:
$10.5
하루 거래량:
1.50M
Relative Volume:
0.71
시가총액:
$1.57B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-7.694
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
-10.74%
1개월 성능:
-0.67%
6개월 성능:
+38.39%
1년 성능:
+155.20%
1일 변동 폭
$10.22
$10.77
1주일 범위
$10.22
$11.65
52주 변동 폭
$3.845
$12.43
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
10.31 | 1.75B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Is Adaptive Biotechnologies Corporation a good long term investmentExceptional earning trajectories - jammulinksnews.com
Principal Financial Group Inc. Purchases 141,691 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Cerity Partners LLC Sells 21,433 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
What analysts say about Adaptive Biotechnologies Corporation stockSky-high return potential - jammulinksnews.com
Teacher Retirement System of Texas Acquires New Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corporation to Announce Second Quarter 2025 Financial Results on August 5, 2025 - Quiver Quantitative
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 - Yahoo Finance
How Adaptive Biotechnologies Corporation stock performs during market volatilityTrade Ready Signal - Newser
What makes Adaptive Biotechnologies Corporation stock price move sharplyHigh Confidence Trade Setups - Newser
Wealth Enhancement Advisory Services LLC Invests $87,000 in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Adaptive Biotechnologies and Flatiron Health Collaborate to Integrate clonoSEQ® Test into OncoEMR® for Enhanced Blood Cancer Care - Quiver Quantitative
Adaptive Biotechnologies Corporation(NasdaqGS:ADPT) added to Russell 3000 Growth Index - MarketScreener
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance
Adaptive Biotechnologies stock hits 52-week high at 10.88 USD By Investing.com - Investing.com South Africa
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet - Benzinga
Rhumbline Advisers Raises Stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Cathie Wood’s ARK buys BWX stock, sells Adaptive Biotech - Investing.com
Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News - GuruFocus
Adaptive Biotechnologies (ADPT) Sees Positive Growth Prospects | - GuruFocus
Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts - Nasdaq
Adaptive Biotechnologies (ADPT) Receives New Buy Rating and Pric - GuruFocus
Adaptive Biotechnologies reports annual meeting outcomes By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies reports annual meeting outcomes - Investing.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Bought by California State Teachers Retirement System - Defense World
Adaptive Biotechnologies at Goldman Sachs Conference: Strong Q1 Performance and Strategic Growth - Investing.com
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
118,593 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Squarepoint Ops LLC Raises Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Nasdaq Today Adaptive Biotechnologies’ Role in Innovation Kalkine - Kalkine Media
ADPT stock soars to 52-week high, hits $10.28 amid surge - Investing.com India
Two Sigma Advisers LP Has $309,000 Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Two Sigma Investments LP Has $1.10 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Bank of America Corp DE - Defense World
Cathie Wood’s ARK buys Guardant Health, sells Adaptive Biotechnologies stock - Investing.com Nigeria
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration - Benzinga
Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at Key Conferences | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers - The Manila Times
Adaptive Biotechnologies’ MRD test featured in cancer studies - Investing.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
BNP Paribas Financial Markets Reduces Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Cathie Wood’s ARK buys CRISPR, sells Adaptive Biotech stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys CRISPR, sells Adaptive Biotech stock - Investing.com
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Janus Henderson Group PLC Buys Shares of 46,900 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):